ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures

[1]  R. Weinberg,et al.  ASNC imaging guidelines for nuclear cardiology procedures , 2017, Journal of Nuclear Cardiology.

[2]  S. Kumita,et al.  The reproducibility of time-of-flight PET and conventional PET for the quantification of myocardial blood flow and coronary flow reserve with 13N-ammonia , 2016, Journal of Nuclear Cardiology.

[3]  Andrew J Einstein,et al.  ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers , 2016, Journal of Nuclear Cardiology.

[4]  M. Nishimura,et al.  The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial 18F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis , 2015, Journal of Nuclear Cardiology.

[5]  N. Crone,et al.  Serious and potentially life threatening complications of cardiac stress testing: Physiological mechanisms and management strategies , 2015, Journal of Nuclear Cardiology.

[6]  A. Sinusas.  Does a shortened hyperemia with regadenoson stress pose a concern for quantitative Rb-82 PET imaging? Optimization of regadenoson PET imaging. , 2015, JACC. Cardiovascular imaging.

[7]  V. Dilsizian,et al.  Capturing maximal coronary vasodilation for myocardial perfusion imaging: is timing everything? , 2015, JACC. Cardiovascular imaging.

[8]  K. Gould,et al.  Regadenoson versus dipyridamole hyperemia for cardiac PET imaging. , 2015, JACC. Cardiovascular imaging.

[9]  R. deKemp,et al.  Biodistribution and radiation dosimetry of 82Rb at rest and during peak pharmacological stress in patients referred for myocardial perfusion imaging , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[10]  B. Prendergast,et al.  Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular S , 2015, The Journal of antimicrobial chemotherapy.

[11]  John O. Prior,et al.  Quantification of myocardial blood flow in absolute terms using (82)Rb PET imaging: the RUBY-10 Study. , 2014, JACC. Cardiovascular imaging.

[12]  A. Lammertsma,et al.  Quantitative assessment of myocardial perfusion in the detection of significant coronary artery disease: cutoff values and diagnostic accuracy of quantitative [(15)O]H2O PET imaging. , 2014, Journal of the American College of Cardiology.

[13]  V. Dilsizian,et al.  Original InvestigationEditorial CommentPET-Determined Hyperemic Myocardial Blood Flow: Further Progress to Clinical Application∗ , 2014 .

[14]  V. Dilsizian.  2014 SNMMI Highlights Lecture: Cardiovascular Imaging. , 2014, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  Amit R. Patel,et al.  HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. , 2014, Heart rhythm.

[16]  E. Miller,et al.  Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis , 2014, Journal of Nuclear Cardiology.

[17]  V. Dilsizian,et al.  Leaning heavily on PET myocardial perfusion for prognosis. , 2014, JACC. Cardiovascular imaging.

[18]  R. Blankstein,et al.  Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis , 2014, Journal of Nuclear Cardiology.

[19]  V. Dilsizian,et al.  The Potential of FDG PET/CT for Early Diagnosis of Cardiac Device and Prosthetic Valve Infection Before Morphologic Damages Ensue , 2014, Current Cardiology Reports.

[20]  F. Bengel,et al.  Advanced Imaging of Cardiac Sarcoidosis , 2014, The Journal of Nuclear Medicine.

[21]  A. Enk,et al.  Radiopharmaceutical Therapy of Patients with Metastasized Melanoma with the Melanin-Binding Benzamide 131I-BA52 , 2014, The Journal of Nuclear Medicine.

[22]  Juhani Knuuti,et al.  Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. , 2013, Journal of the American College of Cardiology.

[23]  S. Achenbach,et al.  Adding or selecting imaging modalities for incremental diagnosis: a case study of ¹⁸FDG PET/CT in prosthetic valve endocarditis. , 2013, JACC. Cardiovascular imaging.

[24]  Abhishek Sharma.  Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis. , 2013, Journal of the American College of Cardiology.

[25]  V. Dilsizian,et al.  SNMMI/ASNC/SCCT Guideline for Cardiac SPECT/CT and PET/CT 1.0* , 2013, The Journal of Nuclear Medicine.

[26]  D. Raoult,et al.  Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion. , 2013, Journal of the American College of Cardiology.

[27]  Martin Rajchl,et al.  Active Cardiac Sarcoidosis: First Clinical Experience of Simultaneous Positron Emission Tomography–Magnetic Resonance Imaging for the Diagnosis of Cardiac Disease , 2013, Circulation.

[28]  U. Kramer,et al.  CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. , 2013, JACC. Cardiovascular imaging.

[29]  Allison R. Schulman,et al.  18F-FDG PET/CT for the Assessment of Myocardial Sarcoidosis , 2013, Current cardiology reports.

[30]  E. Leung,et al.  The role of F18-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis , 2013, Journal of Nuclear Cardiology.

[31]  Vasken Dilsizian,et al.  Journey in evolution of nuclear cardiology: will there be another quantum leap with the F-18-labeled myocardial perfusion tracers? , 2012, JACC. Cardiovascular imaging.

[32]  I. Nault,et al.  Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. , 2012, Journal of the American College of Cardiology.

[33]  V. Gerbaudo,et al.  Occupational radiation dosimetry evaluation using an automated injection device , 2012 .

[34]  D. Dey,et al.  Automated quantitative Rb-82 3D PET/CT myocardial perfusion imaging: Normal limits and correlation with invasive coronary angiography , 2012, Journal of Nuclear Cardiology.

[35]  Ran Klein,et al.  Does quantification of myocardial flow reserve using rubidium-82 positron emission tomography facilitate detection of multivessel coronary artery disease? , 2012, Journal of Nuclear Cardiology.

[36]  Jon Hainer,et al.  Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. , 2012, Journal of the American College of Cardiology.

[37]  Robert A. deKemp,et al.  The Use of 18F-FDG PET in the Diagnosis of Cardiac Sarcoidosis: A Systematic Review and Metaanalysis Including the Ontario Experience , 2012, The Journal of Nuclear Medicine.

[38]  E. V. van Beek,et al.  Assessment of Valvular Calcification and Inflammation by Positron Emission Tomography in Patients With Aortic Stenosis , 2012, Circulation.

[39]  M. Pencina,et al.  Improved Cardiac Risk Assessment With Noninvasive Measures of Coronary Flow Reserve , 2011, Circulation.

[40]  S. Borges-Neto,et al.  Utility of FDG PET/CT in inflammatory cardiovascular disease. , 2011, Radiographics : a review publication of the Radiological Society of North America, Inc.

[41]  Kathryn A. Williams,et al.  Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. , 2011, Journal of the American College of Cardiology.

[42]  M. Budoff,et al.  Predictors of coronary heart disease events among asymptomatic persons with low low-density lipoprotein cholesterol MESA (Multi-Ethnic Study of Atherosclerosis). , 2011, Journal of the American College of Cardiology.

[43]  M. Abrar,et al.  Utility of high fat and low carbohydrate diet in suppressing myocardial FDG uptake , 2011, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[44]  M. Kupari,et al.  Cardiac Sarcoidosis and Giant Cell Myocarditis as Causes of Atrioventricular Block in Young and Middle-Aged Adults , 2011, Circulation. Arrhythmia and electrophysiology.

[45]  M. Lodge,et al.  Radiation Dosimetry of 82Rb in Humans Under Pharmacologic Stress , 2011, The Journal of Nuclear Medicine.

[46]  T. Imaizumi,et al.  Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis. , 2010, JACC. Cardiovascular imaging.

[47]  Vasken Dilsizian,et al.  Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. , 2010, JACC. Cardiovascular imaging.

[48]  E. Campbell,et al.  Metabolic Shifts in Immunity and Inflammation , 2010, The Journal of Immunology.

[49]  V. Dilsizian,et al.  Qualitative and quantitative scrutiny by regulatory process: is the truth subjective or objective? , 2009, JACC. Cardiovascular imaging.

[50]  Oliver Gaemperli,et al.  Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. , 2009, Journal of the American College of Cardiology.

[51]  R. Kwong,et al.  Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF. , 2009, JACC. Cardiovascular imaging.

[52]  M. Gebregziabher,et al.  Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis , 2009, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[53]  Georges El Fakhri,et al.  Reproducibility and Accuracy of Quantitative Myocardial Blood Flow Assessment with 82Rb PET: Comparison with 13N-Ammonia PET , 2009, Journal of Nuclear Medicine.

[54]  A. Fischman,et al.  Comparison of positron emission tomography measurement of adenosine-stimulated absolute myocardial blood flow versus relative myocardial tracer content for physiological assessment of coronary artery stenosis severity and location. , 2009, JACC. Cardiovascular imaging.

[55]  S. Nekolla,et al.  Evaluation of the Novel Myocardial Perfusion Positron-Emission Tomography Tracer 18F-BMS-747158-02: Comparison to 13N-Ammonia and Validation With Microspheres in a Pig Model , 2009, Circulation.

[56]  S. Ben-Haim,et al.  Cardiovascular infection and inflammation. , 2009, Seminars in nuclear medicine.

[57]  V. Dilsizian.  18F-FDG Uptake as a Surrogate Marker for Antecedent Ischemia , 2008, Journal of Nuclear Medicine.

[58]  D. Berman,et al.  Comparison of Myocardial Perfusion 82Rb PET Performed with CT- and Transmission CT–Based Attenuation Correction , 2008, Journal of Nuclear Medicine.

[59]  I. Komuro,et al.  Active myocarditis in a patient with chronic active Epstein-Barr virus infection. , 2008, International journal of cardiology.

[60]  H. William Strauss,et al.  Procedure Guideline for Myocardial Perfusion Imaging 3.3* , 2008, Journal of Nuclear Medicine Technology.

[61]  V. Dilsizian,et al.  Imaging myocardial metabolism and ischemic memory , 2008, Nature Clinical Practice Cardiovascular Medicine.

[62]  F. Bengel,et al.  Comparison of LV function by gated Rb-82 PET with contrast-enhanced CT ventriculography: A hybrid PET-CT analysis , 2008 .

[63]  M. Nishimura,et al.  Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[64]  G. Kolodny,et al.  Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet. , 2008, AJR. American journal of roentgenology.

[65]  André Lamy,et al.  F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). , 2007, Journal of the American College of Cardiology.

[66]  S. Nekolla,et al.  Attenuation correction in cardiac PET/CT with three different CT protocols: a comparison with conventional PET , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[67]  Ran Klein,et al.  Quantification of myocardial blood flow with 82Rb dynamic PET imaging , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[68]  Tinsu Pan,et al.  Frequent Diagnostic Errors in Cardiac PET/CT Due to Misregistration of CT Attenuation and Emission PET Images: A Definitive Analysis of Causes, Consequences, and Corrections , 2007, Journal of Nuclear Medicine.

[69]  R. Kerensky,et al.  Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans , 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[70]  M. D. Di Carli,et al.  Quantitative 82Rb PET/CT: Development and Validation of Myocardial Perfusion Database , 2007, Journal of Nuclear Medicine.

[71]  E. Abel,et al.  Diabetic cardiomyopathy revisited. , 2007, Circulation.

[72]  S. Moore,et al.  Clinical Myocardial Perfusion PET/CT* , 2007, Journal of Nuclear Medicine.

[73]  R. deKemp,et al.  Will 3-dimensional PET-CT enable the routine quantification of myocardial blood flow? , 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[74]  Paul Kinahan,et al.  Cine CT for Attenuation Correction in Cardiac PET/CT , 2007, Journal of Nuclear Medicine.

[75]  U. Sampson,et al.  CT-based attenuation correction versus prone imaging to decrease equivocal interpretations of rest/stress Tc-99m tetrofosmin SPECT MPI , 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[76]  David L Hayes,et al.  Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. , 2007, Archives of internal medicine.

[77]  Uchechukwu Sampson,et al.  Value of vasodilator left ventricular ejection fraction reserve in evaluating the magnitude of myocardium at risk and the extent of angiographic coronary artery disease: a 82Rb PET/CT study. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[78]  B. Chow,et al.  CCS/CAR/CANM/CNCS/CanSCMR joint position statement on advanced noninvasive cardiac imaging using positron emission tomography, magnetic resonance imaging and multidetector computed tomographic angiography in the diagnosis and evaluation of ischemic heart disease--executive summary. , 2007, The Canadian journal of cardiology.

[79]  B. Chow,et al.  Is septal glucose metabolism altered in patients with left bundle branch block and ischemic cardiomyopathy? , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[80]  Stephen L. Bacharach,et al.  PET/CT imaging: Effect of respiratory motion on apparent myocardial uptake , 2006, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[81]  Frank P DiFilippo,et al.  A knowledge-based method for reducing attenuation artefacts caused by cardiac appliances in myocardial PET/CT , 2006, Physics in medicine and biology.

[82]  Georges El Fakhri,et al.  Quantitative dynamic cardiac 82Rb PET using generalized factor and compartment analyses. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[83]  M. Nishimura,et al.  Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. , 2005, European heart journal.

[84]  Frank P DiFilippo,et al.  Do implanted pacemaker leads and ICD leads cause metal-related artifact in cardiac PET/CT? , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[85]  T. Yokoyama,et al.  Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[86]  Terrence D. Ruddy,et al.  Potential utility of rubidium 82 pet quantification in patients with 3-vessel coronary artery disease , 2004, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[87]  Catalin Loghin,et al.  Common artifacts in PET myocardial perfusion images due to attenuation-emission misregistration: clinical significance, causes, and solutions. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[88]  R. Hendel,et al.  American Society of Nuclear Cardiology and Society of Nuclear Medicine joint position statement: Attenuation correction of myocardial perfusion SPECT scintigraphy , 2004, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[89]  M. Coel,et al.  Reduction of myocardial 2-deoxy-2-[18F]fluoro-D-glucose uptake artifacts in positron emission tomography using dietary carbohydrate restriction. , 2002, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[90]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association , 2002, The international journal of cardiovascular imaging.

[91]  T. Ruddy,et al.  Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[92]  J J Bax,et al.  Positron emission tomography using(18)F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community Concerted Action Multicenter study on use of(18)F-fluoro-de , 2001, European heart journal.

[93]  A F Laine,et al.  Use of wavelet transforms in analysis of time-activity data from cardiac PET. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[94]  S L Bacharach,et al.  13N-ammonia myocardial blood flow and uptake: relation to functional outcome of asynergic regions after revascularization. , 1999, Journal of the American College of Cardiology.

[95]  R. deKemp,et al.  Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging. , 1998, Circulation.

[96]  T. Lewellen,et al.  Time-of-flight PET. , 1998, Seminars in nuclear medicine.

[97]  P. Camici,et al.  Coronary artery bypass surgery as treatment for ischemic heart failure: the predictive value of viability assessment with quantitative positron emission tomography for symptomatic and functional outcome. , 1998, The Journal of thoracic and cardiovascular surgery.

[98]  V. Dilsizian,et al.  [18F]fluorodeoxyglucose single photon emission computed tomography: can it replace PET and thallium SPECT for the assessment of myocardial viability? , 1998, Circulation.

[99]  W. Martin,et al.  A simplified intravenous glucose loading protocol for fluorine-18 fluorodeoxyglucose cardiac single-photon emission tomography , 1997, European Journal of Nuclear Medicine.

[100]  R. Huesman,et al.  Consequences of using a simplified kinetic model for dynamic PET data. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[101]  J. Mccormack,et al.  Regulation of energy substrate metabolism in the diabetic heart. , 1997, Cardiovascular research.

[102]  G. Lopaschuk,et al.  Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. , 1997, Cardiovascular research.

[103]  B J Messmer,et al.  Recovery of regional left ventricular dysfunction after coronary revascularization. Impact of myocardial viability assessed by nuclear imaging and vessel patency at follow-up angiography. , 1996, Journal of the American College of Cardiology.

[104]  Jeroen J. Bax,et al.  Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[105]  N. Mullani,et al.  Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[106]  W. Martin,et al.  Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography. , 1995, Journal of the American College of Cardiology.

[107]  S L Bacharach,et al.  Artifactual inhomogeneities in myocardial PET and SPECT scans in normal subjects. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[108]  G. Hutchins,et al.  Heterogeneity of regional nitrogen 13-labeled ammonia tracer distribution in the normal human heart: Comparison with rubidium 82 and copper 62-labeled PTSM , 1994, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[109]  M. Phelps,et al.  Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. , 1994, The American journal of cardiology.

[110]  M. Phelps,et al.  Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-d-glucose uptake in positron emission tomography studies of normal humans , 1993, European Journal of Nuclear Medicine.

[111]  U. Ruotsalainen,et al.  Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[112]  P. Herrero,et al.  Implementation and evaluation of a two-compartment model for quantification of myocardial perfusion with rubidium-82 and positron emission tomography. , 1992, Circulation research.

[113]  F. Fazio,et al.  Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[114]  M. Phelps,et al.  Parametric images of myocardial metabolic rate of glucose generated from dynamic cardiac PET and 2-[18F]fluoro-2-deoxy-d-glucose studies. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[115]  P. Herrero,et al.  Noninvasive quantification of regional myocardial perfusion with rubidium-82 and positron emission tomography. Exploration of a mathematical model. , 1990, Circulation.

[116]  D E Kuhl,et al.  Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. , 1990, Journal of the American College of Cardiology.

[117]  M E Phelps,et al.  13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. , 1989, Circulation.

[118]  M. Walsh,et al.  Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography. , 1989, Journal of the American College of Cardiology.

[119]  H. Griffiths,et al.  Radiation Dose to Patients from Radiopharmaceuticals. ICRP Publication 53 , 1988 .

[120]  H. Ehmke,et al.  Influence of the renin-angiotensin system on the autoregulation of renal blood flow and glomerular filtration rate in conscious dogs. , 1988, Acta physiologica Scandinavica.

[121]  F Shishido,et al.  Measurement of absolute myocardial blood flow with H215O and dynamic positron-emission tomography. Strategy for quantification in relation to the partial-volume effect. , 1988, Circulation.

[122]  Icrp.  Radiation dose to patients from radiopharmaceuticals , 1988 .

[123]  M Schwaiger,et al.  Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. , 1986, The New England journal of medicine.

[124]  K. Hamacher,et al.  Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[125]  M J Welch,et al.  Quantification of regional myocardial blood flow in vivo with H2150* , 2005 .

[126]  Michel M. Ter-Pogossian,et al.  Super PETT I: A Positron Emission Tomograph Utilizing Photon Time-of-Flight Information , 1983, IEEE Transactions on Medical Imaging.

[127]  N. Mullani,et al.  Myocardial perfusion with rubidium-82. II. Effects of metabolic and pharmacologic interventions. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[128]  M E Phelps,et al.  Identification and Differentiation of Resting Myocardial Ischemia and Infarction in Man with Positron Computed Tomography, 18F‐labeled Fluorodeoxyglucose and N‐13 Ammonia , 1983, Circulation.

[129]  M E Phelps,et al.  Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. , 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[130]  H A O'Brien,et al.  Relation between regional myocardial uptake of rubidium-82 and perfusion: absolute reduction of cation uptake in ischemia. , 1982, The American journal of cardiology.

[131]  M. Phelps,et al.  Dependence of /sup 13/NH/sub 3/ myocardial extraction and clearance on flow and metabolism. [Rabbits] , 1982 .

[132]  M. Phelps,et al.  Dependence of 13NH3 myocardial extraction and clearance on flow and metabolism. , 1982, The American journal of physiology.

[133]  D. Kuhl,et al.  N‐13 Ammonia as an Indicator of Myocardial Blood Flow , 1981, Circulation.

[134]  M. Brown,et al.  Gallium scintigraphy in the evaluation of disk-space infections: concise communication. , 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[135]  M. Welch,et al.  The Dependence of Accumulation of 13NH3 by Myocardium on Metabolic Factors and Its Implications for Quantitative Assessment of Perfusion , 1980, Circulation.

[136]  S. Wattrus,et al.  A dose-response study of the anticoagulant and lipolytic activities of heparin in normal subjects. , 1979, British journal of clinical pharmacology.

[137]  G. Hutchins,et al.  Cardiac Sarcoid: A Clinicopathologic Study of 84 Unselected Patients with Systemic Sarcoidosis , 1978, Circulation.

[138]  K. Iwai,et al.  CLINICOPATHOLOGICAL STUDY ON FATAL MYOCARDIAL SARCOIDOSIS * , 1976, Annals of the New York Academy of Sciences.

[139]  J. Oram,et al.  Myocardial utilization of carbohydrate and lipids. , 1972, Progress in cardiovascular diseases.

[140]  W. D. Love,et al.  Influence of the Rate of Coronary Plasma Flow on the Extraction of Rb86 from Coronary Blood , 1959, Circulation research.

[141]  V. Dilsizian,et al.  PET-determined hyperemic myocardial blood flow: further progress to clinical application. , 2014, Journal of the American College of Cardiology.

[142]  J. Le Heuzey,et al.  Whole body [(18) F]fluorodeoxyglucose positron emission tomography imaging for the diagnosis of pacemaker or implantable cardioverter defibrillator infection: a preliminary prospective study. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[143]  M. C. Ling,et al.  Right and left ventricular uptake with Rb-82 PET myocardial perfusion imaging: Markers of left main or 3 vessel disease , 2010, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[144]  M. Nishimura,et al.  Images in cardiovascular medicine: Imaging of cardiac sarcoid lesions using fasting cardiac 18F-fluorodeoxyglucose positron emission tomography: an autopsy case. , 2010, Circulation.

[145]  Michael G. Stabin,et al.  Radiation Dose to Patients from Radiopharmaceuticals , 2009 .

[146]  B. Mulder,et al.  Surgical glue for repair of the aortic root as a possible explanation for increased F-18 FDG uptake , 2008, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[147]  Icrp,et al.  Radiation dose to patients from radiopharmaceuticals. Addendum 3 to ICRP Publication 53. ICRP Publication 106. Approved by the Commission in October 2007. , 2008, Annals of the ICRP.

[148]  John D Friedman,et al.  Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: Comparison with ECG-gated Tc-99m sestamibi SPECT , 2006, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[149]  T. Pruett.  Staphylococcus aureus Bacteremia in Patients With Prosthetic Devices: Costs and Outcomes , 2006 .

[150]  G. Muehllehner,et al.  Positron emission tomography , 2006, Physics in medicine and biology.

[151]  V. Dilsizian,et al.  Fluorine-18-deoxyglucose SPECT and coincidence imaging for myocardial viability: clinical and technologic issues , 2001, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[152]  M. Croitoru.  Myocardial Viability: A Clinical and Scientific Treatise , 2000 .

[153]  R. Gropler,et al.  Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[154]  E. Persson.  Lipoprotein lipase, hepatic lipase and plasma lipolytic activity. Effects of heparin and a low molecular weight heparin fragment (Fragmin). , 1988, Acta medica Scandinavica. Supplementum.

[155]  M. Ter-pogossian,et al.  Experimental Assessment of the Gain Achieved by the Utilization of Time-of-Flight Information in a Positron Emission Tomograph (Super PETT I) , 1982, IEEE Transactions on Medical Imaging.

[156]  J R Neely,et al.  Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. , 1974, Annual review of physiology.